LEADER 02676nam 2200433 450 001 9910780709103321 005 20240112051738.0 010 $a92-0-127322-3 035 $a(MiAaPQ)EBC30589736 035 $a(Au-PeEL)EBL30589736 035 $a(OCoLC)1239992646 035 $a(EXLCZ)9926864584700041 100 $a20240112d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTherapeutic Radiopharmaceuticals Labelled with Copper-67, Rhenium-186 and Scandium-47 /$fInternational Atomic Energy Agency 205 $aFirst edition. 210 1$aVienna, Austria :$cInternational Atomic Energy Agency,$d[2021] 210 4$dİ2021 215 $a1 online resource (58 pages) 311 08$aPrint version: IAEA Therapeutic Radiopharmaceuticals Labelled with Copper-67, Rhenium-186 and Scandium-47 Vienna : International Atomic Energy Agency,c2021 9789201272225 330 $aTheranostic radiopharmaceuticals have shown tremendous capabilities in the last decade in the treatment and diagnosis of human diseases via nuclear medicine procedures. In particular, the use of radiometals has experienced a great increase as a result of the development of relevant production technologies. This publication presents the outcome of an IAEA coordinated research project (CRP) focusing on the production, quality control and radiopharmaceutical aspects of three key radionuclides, 67CU, 186Re and 47Sc, which have been selected based on their theranostic potential and their dual production routes. The publication was compiled using inputs from experts in the field as well as presenting the overall results of the CRP. It contains separate sections for each radionuclide including: nuclear data and information on targetry, irradiation, chemical separation, quality control as well as sample radiopharmaceutical production. The findings and considerations will be of use to scientists and technologists interested in translating research reactor and cyclotron based radioisotope production into practice, as well as to post graduate students in the field. 606 $aRadioisotope scanning 606 $aRadiopharmaceuticals 606 $aRadioisotopes in pharmacology 615 0$aRadioisotope scanning. 615 0$aRadiopharmaceuticals. 615 0$aRadioisotopes in pharmacology. 676 $a616.07/575 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910780709103321 996 $aTherapeutic radiopharmaceuticals labelled with Copper-67, Rhenium-186 and Scandium-47$93738976 997 $aUNINA